Skip to content

A comparative study of dexibuprofen or celecoxib for neurosurgical over-the-counter and postoperative analgesia

A comparative study of dexibuprofen or celecoxib for neurosurgical over-the-counter and postoperative analgesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104114
Enrollment
Unknown
Registered
2025-06-11
Start date
2025-04-11
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperalgesia and postoperative analgesia

Interventions

Group P:1~1.5h before induction of anesthesia: no preoperative medication Postoperative wakefulness (after being able to drink water): patient (NRS score =3) took 2 oral dexibuprofen capsules
Group D:1~1.5h before induction of anesthesia: 2 capsules of dexibuprofen given by the study coordinator, 5~10ml of warm water. Postoperative wakefulness: same as group P.
Group C:Before induction of anesthesia 1-1.5h: 2 capsules of celecoxib were given by the study coordinator with 5-10ml of warm water. Postoperative wakefulness: 1 capsule of celecoxib was given orally

Sponsors

Sanbo Brain Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists ASAI to Class II patients after elective neurosurgical craniotomy; 2. Patients aged 18 to 60 years old (including 18 years old as well as 60 years old) of both sexes; 3. Subjects voluntarily agreed to participate in this study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiac, hepatic, or renal dysfunction or other serious systemic diseases; 2. Patients with suspected or a history of alcohol or drug abuse; 3. Post-neurosurgical patients requiring prolonged sedation or mechanical ventilation; 4. Patients with a known hypersensitivity to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), particularly those who have experienced asthma, neurovascular edema, or shock following exposure; 5. Patients currently participating in another clinical trial involving investigational drugs prior to enrollment; 6. Patients with hearing, visual, or speech impairments that may interfere with the ability to complete study assessments; 7. Patients with a history of active peptic ulcer disease or gastrointestinal bleeding or perforation of any known cause; 8. Patients with coagulation disorders or those receiving anticoagulant therapy; 9. Patients undergoing intraoperative neurophysiological monitoring, such as those with posterior cranial fossa tumors; 10. Patients with swallowing disorders or dysphagia.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure during anterior and posterior upper head frame, skinning, sawing the skull, clipping the dura mater, removing the middle of the tumor, hemostasis, suturing the dura mater, repositioning the bone flap, suturing the fascia, and suturing the skin;Heart rate during anterior and posterior upper head frame, skinning, sawing the skull, cutting the dura, removing the tumor center, hemostasis, suturing the dura, bone flap repositioning, suturing the fascia, and suturing the skin;End-expiratory sevoflurane concentration during anterior and posterior upper head frame, skinning, sawing the skull, cutting the dura, removing the tumor midway, hemostasis, suturing the dura, repositioning the bone flap, suturing the fascia, and suturing the skin;Minimum effective concentration of alveoli during anterior and posterior upper head frame, skinning, sawing of the skull, cutting of the dura mater, removal of the tumor center, hemostasis, suturing of the dura mater, repositioning of the bone flap, suturing of the fascia, and suturing of the skin;NRS scores in the quiet state and in the coughing state were assessed at 8-10 am and 16-18 pm on postoperative days 1, 2, and 3 in all three groups.;Recovery time of spontaneous respiration, recovery time of orientation, and extubation time of patients in 3 groups;

Secondary

MeasureTime frame
Heart rate, blood pressure, respiration, and body temperature before and 1 minute, 3 minutes, and 5 minutes after intubation for induction of general anesthesia;Patient anesthesia time, surgery time;Incidence of hypertension, arrhythmia, agitation and chills during recovery from anesthesia;Occurrence and incidence of adverse reactions in patients after drug administration;

Countries

China

Contacts

Public ContactWang Baoguo

Sanbo Brain Hospital of Capital Medical University

15194954857@163.com+86 151 9495 4857

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026